The Comparison of Four Different Treatment Modalities in Bulky Stage Ib ve IIa Cervix Cancers
PDF
Cite
Share
Request
Clinical Investigation
P: 42-47
March 2013

The Comparison of Four Different Treatment Modalities in Bulky Stage Ib ve IIa Cervix Cancers

Turk J Obstet Gynecol 2013;10(1):42-47
1. Department Of Gynecologic Oncology, Aegean Obstetrics And Gynecology Education And Research Hospital, Izmir, Turkey
No information available.
No information available
PDF
Cite
Share
Request

ABSTRACT

Aim:

To compare the effectiveness of four different treatment modalities in International Federation of Gynecology and Obstetrics (FIGO) Ib2 and IIa2 bulky cervix cancers.

Material and Method:

Totally, n = 70 eligible women with bulky (≥4 cm) FIGO Ib2 - IIa2 cervical cancer diagnosed and treated at our clinic between the years of 1/1994 - 1/2010 were investigated retrospectively. Data regarding demographic and disease related characteristics were obtained for analysis from patients' files. Different treatment modalities (radical hysterectomy followed by adjuvant chemoradiation (RH + CTRT); primary chemoradiotherapy (CTRT); neoadjuvant chemotherapy followed by radical hysterectomy (NACT + RH) and neoadjuvant chemoradiotherapy followed by radical hysterectomy (NACRT + RH) were compared in terms of disease-free survival (DFS) and overall survival (OS) by Kaplan-Meier test. A p value of less than 0.05 was accepted as statistically significant.

Results:

Sixty-three patients (90%) had Stage Ib2 and seven (10%) had stage IIa2 disease. (RH + CRT), primary (CTRT), (NACT + RH) and (NACRT + RH) were performed to 32, 23, 10 and 5 patients, respectively. Mean follow-up period was 78.1 ± 51.6 months [range: 10-210]. Thirteen patients (18.6%) developed recurrence and 10 (14.3%) died from disease. Mean DFS and OS were 64.6 ± 46.7 [4-210] and 68.2 ± 47.3 [10-210] months; respectively. No statistically significant difference was found in terms of survival between four treatment methods (p = 0.85 for DFS and p = 0.9 for OS).

Conclusion:

The effectiveness of four treatment modalities were similar in terms of survival for patients with bulky FIGO stage Ib2 and IIa2 cervical cancers.

Keywords:
Bulky stage 1b-2a cervix cancer, radical hysterectomy, primary chemoradiotherapy neoadjuvant chemotherapy, neoadjuvant radiotherapy